Klemen Kodrič1, Klemen Čamernik1, Darko Černe1, Radko Komadina2, Janja Marc3. 1. Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Askerceva cesta 7, 1000, Ljubljana, Slovenia. 2. General and Teaching Hospital Celje, Celje, Slovenia. 3. Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Askerceva cesta 7, 1000, Ljubljana, Slovenia. janja.marc@ffa.uni-lj.si.
Abstract
BACKGROUND: Osteoporosis is the most frequent bone metabolic disease. In order to improve early detection, prediction, prevention, diagnosis, and treatment of the disease, a new model of P4 medicine (personalized, predictive, preventive, and participatory medicine) could be applied. The aim of this work was to systematically review the publications of four different types of "omics" studies related to osteoporosis, in order to discover novel predictive, preventive, diagnostic, and therapeutic targets for better management of the geriatric population. METHODS: To systematically search the PubMed database, we created specific groups of criteria for four different types of "omics" information on osteoporosis: genomic, transcriptomic, proteomic, and metabolomic. We then analyzed the intersections between them in order to find correlations and common pathways or molecules with important roles in osteoporosis, and with a potential application in disease prediction, prevention, diagnosis, or treatment. RESULTS: Altogether, 180 publications of "omics" studies in the field of osteoporosis were found and reviewed at first selection. After introducing the inclusion and exclusion criteria (the secondary selection), 46 papers were included in the systematic review. CONCLUSIONS: The intersection of reviewed papers identified five genes (ESR1, IBSP, CTNNB1, SOX4, and IDUA) and processes like the Wnt pathway, JAK/STAT signaling, and ERK/MAPK, which should be further validated for their predictive, diagnostic, or other clinical value in osteoporosis. Such molecular insights will enable us to fit osteoporosis into the P4 strategy and could increase the effectiveness of disease prediction and prevention, with a decrease in morbidity in the geriatric population.
BACKGROUND:Osteoporosis is the most frequent bone metabolic disease. In order to improve early detection, prediction, prevention, diagnosis, and treatment of the disease, a new model of P4 medicine (personalized, predictive, preventive, and participatory medicine) could be applied. The aim of this work was to systematically review the publications of four different types of "omics" studies related to osteoporosis, in order to discover novel predictive, preventive, diagnostic, and therapeutic targets for better management of the geriatric population. METHODS: To systematically search the PubMed database, we created specific groups of criteria for four different types of "omics" information on osteoporosis: genomic, transcriptomic, proteomic, and metabolomic. We then analyzed the intersections between them in order to find correlations and common pathways or molecules with important roles in osteoporosis, and with a potential application in disease prediction, prevention, diagnosis, or treatment. RESULTS: Altogether, 180 publications of "omics" studies in the field of osteoporosis were found and reviewed at first selection. After introducing the inclusion and exclusion criteria (the secondary selection), 46 papers were included in the systematic review. CONCLUSIONS: The intersection of reviewed papers identified five genes (ESR1, IBSP, CTNNB1, SOX4, and IDUA) and processes like the Wnt pathway, JAK/STAT signaling, and ERK/MAPK, which should be further validated for their predictive, diagnostic, or other clinical value in osteoporosis. Such molecular insights will enable us to fit osteoporosis into the P4 strategy and could increase the effectiveness of disease prediction and prevention, with a decrease in morbidity in the geriatric population.
Entities:
Keywords:
Geriatrics; Omics; Osteoporosis biomarkers; Personalized medicine; Systems biology
Authors: Unnur Styrkarsdottir; Bjarni V Halldorsson; Solveig Gretarsdottir; Daniel F Gudbjartsson; G Bragi Walters; Thorvaldur Ingvarsson; Thorbjorg Jonsdottir; Jona Saemundsdottir; Jacqueline R Center; Tuan V Nguyen; Yu Bagger; Jeffrey R Gulcher; John A Eisman; Claus Christiansen; Gunnar Sigurdsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson Journal: N Engl J Med Date: 2008-04-29 Impact factor: 91.245
Authors: Emma L Duncan; Patrick Danoy; John P Kemp; Paul J Leo; Eugene McCloskey; Geoffrey C Nicholson; Richard Eastell; Richard L Prince; John A Eisman; Graeme Jones; Philip N Sambrook; Ian R Reid; Elaine M Dennison; John Wark; J Brent Richards; Andre G Uitterlinden; Tim D Spector; Chris Esapa; Roger D Cox; Steve D M Brown; Rajesh V Thakker; Kathryn A Addison; Linda A Bradbury; Jacqueline R Center; Cyrus Cooper; Catherine Cremin; Karol Estrada; Dieter Felsenberg; Claus-C Glüer; Johanna Hadler; Margaret J Henry; Albert Hofman; Mark A Kotowicz; Joanna Makovey; Sing C Nguyen; Tuan V Nguyen; Julie A Pasco; Karena Pryce; David M Reid; Fernando Rivadeneira; Christian Roux; Kari Stefansson; Unnur Styrkarsdottir; Gudmar Thorleifsson; Rumbidzai Tichawangana; David M Evans; Matthew A Brown Journal: PLoS Genet Date: 2011-04-21 Impact factor: 5.917
Authors: Lavinia Paternoster; Mattias Lorentzon; Liesbeth Vandenput; Magnus K Karlsson; Osten Ljunggren; Andreas Kindmark; Dan Mellstrom; John P Kemp; Caroline E Jarett; Jeff M P Holly; Adrian Sayers; Beate St Pourcain; Nicholas J Timpson; Panos Deloukas; George Davey Smith; Susan M Ring; David M Evans; Jon H Tobias; Claes Ohlsson Journal: PLoS Genet Date: 2010-11-18 Impact factor: 5.917
Authors: Lei Zhang; Hyung Jin Choi; Karol Estrada; Paul J Leo; Jian Li; Yu-Fang Pei; Yinping Zhang; Yong Lin; Hui Shen; Yao-Zhong Liu; Yongjun Liu; Yingchun Zhao; Ji-Gang Zhang; Qing Tian; Yu-ping Wang; Yingying Han; Shu Ran; Rong Hai; Xue-Zhen Zhu; Shuyan Wu; Han Yan; Xiaogang Liu; Tie-Lin Yang; Yan Guo; Feng Zhang; Yan-fang Guo; Yuan Chen; Xiangding Chen; Lijun Tan; Lishu Zhang; Fei-Yan Deng; Hongyi Deng; Fernando Rivadeneira; Emma L Duncan; Jong Young Lee; Bok Ghee Han; Nam H Cho; Geoffrey C Nicholson; Eugene McCloskey; Richard Eastell; Richard L Prince; John A Eisman; Graeme Jones; Ian R Reid; Philip N Sambrook; Elaine M Dennison; Patrick Danoy; Laura M Yerges-Armstrong; Elizabeth A Streeten; Tian Hu; Shuanglin Xiang; Christopher J Papasian; Matthew A Brown; Chan Soo Shin; André G Uitterlinden; Hong-Wen Deng Journal: Hum Mol Genet Date: 2013-11-17 Impact factor: 6.150